Medical/Healthcare News

Vittoria Biotherapeutics Wins FDA Clearance for VIPER-101 in T-Cell Lymphoma, Paving the Way for Innovative CAR-T Therapy

PHILADELPHIA, PA — Vittoria Biotherapeutics has hit a significant milestone with the U.S. Food and Drug Administration (FDA) clearing its Investigational New Drug (IND) application for VIPER-101, the company’s leading …

Vittoria Biotherapeutics Wins FDA Clearance for VIPER-101 in T-Cell Lymphoma, Paving the Way for Innovative CAR-T Therapy Read More

Virpax Pharmaceuticals

NRx Pharmaceuticals

NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug Application for NRX-101 to Treat Chronic Pain

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recenlty announced that FDA has given the company clearance to proceed with human trials to treat Chronic Pain under the Investigational New Drug (IND) …

NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug Application for NRX-101 to Treat Chronic Pain Read More
NRx Pharmaceuticals
Venatorx Pharmaceuticals

FDA Accepts Venatorx Pharmaceuticals’ New Drug Application for Cefepime-Taniborbactam

MALVERN, PA — Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) recenlty accepted the company’s New Drug Application (NDA) for cefepime-taniborbactam, an investigational beta-lactam/beta-lactamase inhibitor (BL/BLI) antibiotic …

FDA Accepts Venatorx Pharmaceuticals’ New Drug Application for Cefepime-Taniborbactam Read More